AI assistant
BiomX Inc. — Director's Dealing 2026
Jan 16, 2026
35099_dirs_2026-01-16_56dad093-63b9-4403-8cc6-10f506b18a7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2026-01-13
Reporting Person: Yeganeh Reuven (Director, 10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series Y Convertible Preferred Stock | $2.00 | 2026-12-29 | Common Stock (1650000) | Indirect | |
| Common Stock Purchase Warrants | $2.00 | 2031-01-02 | Common Stock (3300000) | Indirect |
Footnotes
F1: Each share of Series Y Convertible Preferred Stock is initially convertible into common stock at a conversion price of $2.00 per share, subject to customary anti-dilution adjustments for stock splits, stock dividends, recapitalizations and similar transactions. In addition, upon receipt of the requisite stockholder approval, the conversion price may be adjusted as provided in the Certificate of Designation.
F2: The reported securities are held by Pyu Pyu Capital, LLC, of which the reporting person is the sole member, and over which the reporting person exercises sole voting and dispositive power.